{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:27:54Z","timestamp":1789126074656,"version":"build-2803163510"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.<\/jats:p>","DOI":"10.3389\/fmed.2021.798095","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T01:29:37Z","timestamp":1638322177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report"],"prefix":"10.3389","volume":"8","author":[{"given":"Serge","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Vierasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Dewispelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Cogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E296","DOI":"10.1148\/radiol.2021210275","article-title":"Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients","volume":"300","author":"\u00d6z\u00fctemiz","year":"2021","journal-title":"Radiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00259-021-05314-2","article-title":"Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation","volume":"48","author":"Cohen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1002\/cam4.3226","article-title":"Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma","volume":"9","author":"Kitadate","year":"2020","journal-title":"Cancer Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.acra.2021.04.007","article-title":"Lymphadenopathy following COVID-19 vaccination: imaging findings review","volume":"28","author":"Keshavarz","year":"2021","journal-title":"Acad Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/RLU.0000000000003711","article-title":"evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET\/CT following 2-dose COVID-19 vaccination","volume":"46","author":"Weeks","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003859","article-title":"Features of systemic immune response from COVID-19 vaccination on 18F-FDG PET\/CT","author":"Nawwar","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","article-title":"COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT","volume":"46","author":"Xu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/ph14080762","article-title":"Prevalence and significance of hypermetabolic lymph nodes detected by 2-[(18)F]FDG PET\/CT after COVID-19 vaccination: a systematic review and a meta-analysis","volume":"14","author":"Treglia","year":"2021","journal-title":"Pharmaceuticals."},{"key":"B13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/RLU.0000000000003800","article-title":"COVID-19 vaccination\u2013associated lymphadenopathy on FDG PET\/CT: distinctive features in adenovirus-vectored vaccine","volume":"46","author":"Shin","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40336-021-00430-3","article-title":"PET findings after COVID-19 vaccination: \u201cKeep Calm and Carry On","volume":"9","author":"Treglia","year":"2021"},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.celrep.2017.10.044","article-title":"Cytosolic recognition of RNA drives the immune response to heterologous erythrocytes","volume":"21","author":"Loetsch","year":"2017","journal-title":"Cell Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2021.8828","article-title":"Effect of bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities: a randomized clinical trial","volume":"326","author":"Cohen","year":"2021","journal-title":"JAMA"},{"key":"B18","unstructured":"GoldmanS\n            BronD\n            TousseynT\n            VierasuI\n            DewispelaereL\n            HeimannP\n          Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot. A Case Report"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.798095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T01:29:39Z","timestamp":1638322179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.798095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":18,"alternative-id":["10.3389\/fmed.2021.798095"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.798095","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"article-number":"798095"}}